Abstract: A hydroformylation catalyst having excellent catalytic activity and stability, a composition including the hydroformylation catalyst, and a method of preparing an aldehyde using the hydroformylation catalyst, wherein, when hydroformylation of an olefin compound is performed in the presence of the hydroformylation catalyst to prepare an aldehyde, the normal/iso (n/i) ratio of the prepared aldehyde is lowered, and synthesis gas yield is increased.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting DLK1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically, uses for such ADCs in producing drugs for treatment and/or prevention of proliferative and/or angiogenetic diseases, for example, cancer. More particularly, the present invention relates to an antibody-drug conjugate comprising an antibody binding with DLK1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to compositions containing a pterosin compound and derivatives thereof as active ingredients for the prevention or treatment of degenerative brain diseases and, more specifically, to a pharmaceutical composition for the prevention or treatment of degenerative brain diseases and a food composition for the prevention or alleviation of degenerative brain diseases, each of which contains a pterosin compound defined by chemical formula 1 or a derivative thereof as an active ingredient. A method of the present invention can be favorably used to provide a therapeutic agent for preventing or treating degenerative brain diseases, a food for alleviating degenerative brain diseases, or a functional food for the promotion of cognitive functions, by using a pterosin compound extracted from Pteridium aquilinum and derivatives thereof.

Abstract: The present invention relates to a novel pyrrolobenzodiazepine dimer compound or a pharmaceutically acceptable salt thereof, a ligand-drug conjugate compound thereof, or a composition containing the same and therapeutic use of the same as an anticancer agent. The pyrrolobenzodiazepine dimer compound according to the present invention exhibits anticancer activity equivalent to or superior to that of existing anticancer agents when being applied to a ligand-drug conjugate as a drug and administered as well as exhibits low activity and greatly diminished toxicity in the free toxin form and thus has a significantly improved therapeutic index. Hence, the pyrrolobenzodiazepine dimer compound is highly industrially applicable in that targeting of proliferative diseases such as cancer is possible, specific treatment of the proliferative diseases is possible, the drug efficacy can be maximized, and the expression of side effects can be minimized.

Abstract: The present invention relates to a catalyst composition for hydroformylation and a method of preparing an aldehyde using the same. More specifically, the present invention provides a catalyst composition for hydroformylation including a specific phosphite-based ligand and a transition metal compound in a specific amount range, thereby being capable of greatly lowering a use amount of an expensive transition metal compound and exhibiting excellent catalyst activity or stability. In addition, by using the catalyst composition in hydroformylation, excellent reaction efficiency may be provided and iso-aldehyde may be generated in high yield.

Abstract: A method for preparing dimethylolbutanal including performing an aldol reaction of n-butyraldehyde (n-BAL) and paraformaldehyde (PFA) in the presence of water and an alkylamine catalyst, in which a weight ratio of the paraformaldehyde:water is 1:0.35 to 1:0.85.

Abstract: A hydroformylation catalyst having excellent catalytic activity and stability, a composition including the hydroformylation catalyst, and a method of preparing an aldehyde using the hydroformylation catalyst, wherein, when hydroformylation of an olefin compound is performed in the presence of the hydroformylation catalyst to prepare an aldehyde, the normal/iso (n/i) ratio of the prepared aldehyde is lowered, and synthesis gas yield is increased.

Abstract: A method for preparing trimethylolpropane, the method including: subjecting dimethylolbutanal (DMB) to a hydrogenation reaction in the presence of a metal catalyst and an alcohol solvent. During the hydrogenation reaction, a weight ratio of the alcohol solvent based to dimethylolbutanal is 2 to 10.

Abstract: The present invention relates to a catalyst composition for hydroformylation and a method of preparing an aldehyde using the same. More specifically, the present invention provides a catalyst composition for hydroformylation including a specific phosphite-based ligand and a transition metal compound in a specific amount range, thereby being capable of greatly lowering a use amount of an expensive transition metal compound and exhibiting excellent catalyst activity or stability. In addition, by using the catalyst composition in hydroformylation, excellent reaction efficiency may be provided and iso-aldehyde may be generated in high yield.

Abstract: A method for producing dimethylolbutanal, the method including: (A) distilling a raw material comprising dimethylolbutanal (DMB) in a distillation column; (B) separating the distilled raw material in the distillation column into a low boiling point component, dimethylolbutanal, and a high boiling point component; and (C) refluxing a portion or all of the high boiling point component to the distillation column by heating the portion or all of the high boiling point component, in which the dimethylolbutanal is separated from a side cut of the distillation column.

Abstract: A hydroformylation catalyst having excellent catalytic activity and stability, a composition including the hydroformylation catalyst, and a method of preparing an aldehyde using the hydroformylation catalyst, wherein, when hydroformylation of an olefin compound is performed in the presence of the hydroformylation catalyst to prepare an aldehyde, the normal/iso (n/i) ratio of the prepared aldehyde is lowered, and synthesis gas yield is increased.

Abstract: A method for preparing dimethylolbutanal including performing an aldol reaction of n-butyraldehyde (n-BAL) and paraformaldehyde (PFA) in the presence of water and an alkylamine catalyst, in which a weight ratio of the paraformaldehyde:water is 1:0.35 to 1:0.85.

Abstract: A method for producing dimethylolbutanal, the method including: (A) distilling a raw material comprising dimethylolbutanal (DMB) in a distillation column; (B) separating the distilled raw material in the distillation column into a low boiling point component, dimethylolbutanal, and a high boiling point component; and (C) refluxing a portion or all of the high boiling point component to the distillation column by heating the portion or all of the high boiling point component, in which the dimethylolbutanal is separated from a side cut of the distillation column.

Abstract: A method for preparing trimethylolpropane, the method including: subjecting dimethylolbutanal (DMB) to a hydrogenation reaction in the presence of a metal catalyst and an alcohol solvent. During the hydrogenation reaction, a weight ratio of the alcohol solvent based to dimethylolbutanal is 2 to 10.

Abstract: The present invention relates to a composition comprising osmundacetone or a pharmaceutically acceptable salt thereof for preventing or treating bone diseases. More specifically, the present invention relates to: a composition comprising osmundacetone, a pharmaceutically acceptable salt thereof, or an Osmunda japonica extract as an effective ingredient, for preventing or treating osteoporosis, rheumatoid arthritis, arthralgia, Paget disease, bone metastatic cancer, or fracture; a food composition for improvement; a use of a salt; and a treatment method.

Abstract: A diagnostic cartridge includes a chip, in which a channel connecting an inlet and an outlet of the liquid is formed, a biosensor adjacent to the channel, and a circuit for supplying power to the biosensor, and when the target material binds to the biosensor, the resistance of the biosensor may be changed.

Abstract: The present invention relates to a catalyst composition for hydroformylation and a hydroformylation method using the same, and more particularly to a catalyst composition for hydroformylation including a phosphoramidite ligand and a transition metal catalyst, and a hydroformylation method using the catalyst composition. In accordance with the present invention, provided are a catalyst composition for hydroformylation which increases productivity and provides superior catalytic activity and stability while lowering an n/i ratio in generated aldehyde upon hydroformylation of an olefinic compound, and a method of hydroformylating an olefinic compound using the catalyst composition. [Representative Figure] FIG.

Abstract: Provided is a method and apparatus for calculating a safety grade of a working environment that may receive harmful gas information from a gas sensor configured to detect a harmful gas to calculate a safety grade, receive biometric information of a user from a biometric sensor configured to measure the biometric information of the user, calculate a safety grade for the user based on the harmful gas information and the biometric information, and output the calculated safety grade.

Abstract: Provided is a method and apparatus for calculating a safety grade of a working environment that may receive harmful gas information from a gas sensor configured to detect a harmful gas to calculate a safety grade, receive biometric information of a user from a biometric sensor configured to measure the biometric information of the user, calculate a safety grade for the user based on the harmful gas information and the biometric information, and output the calculated safety grade.

Abstract: The present invention relates to a catalyst composition including a phosphorous-based ligand, and a hydroformylation method using the catalyst composition. More particularly, the present invention relates to a catalyst composition, which includes two different kinds of monocoordinated phosphine ligands and a transition metal catalyst, and a hydroformylation method using the catalyst composition. In accordance with the present invention, a catalyst composition lowering a selection ratio of normal aldehyde to iso aldehyde (n/i ratio), which are generated during hydroformylation of an olefinic compound, and exhibiting superior catalytic activity and stability, and a method of hydroformylating an olefinic compound using the catalyst composition are provided.